Press release
Treatment Resistant Hypertension Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight
Download DelveInsight's comprehensive Treatment-Resistant Hypertension Pipeline Report to explore emerging therapies, key Companies, and future treatment landscapes @ https://www.delveinsight.com/sample-request/treatment-resistant-depression-pipeline-insight [https://www.delveinsight.com/sample-request/treatment-resistant-depression-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Treatment-Resistant Hypertension Pipeline Report
* On January 12, 2026- United Therapeutics conducted a Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH.
* DelveInsight's Treatment Resistant Hypertension pipeline report depicts a robust space with 25+ active players working to develop 25+ pipeline therapies for Treatment Resistant Hypertension treatment.
* The leading Treatment Resistant Hypertension Companies such as Axsome Therapeutics, COMPASS Pathways, Merck Sharp & Dohme Corp., Navitor Pharmaceuticals, Inc., Taisho Pharmaceutical Co., Ltd., GH Research Limited, Novartis Pharmaceuticals, Reckitt Benckiser LLC, Relmada Therapeutics, Inc., SAGE Therapeutics, Navitor Pharmaceuticals, Sumitomo Dainippon Pharma, Alkermes, AbbVie, Janssen Pharmaceuticals, Celon Pharma, ACADIA Pharmaceuticals, Pherin Pharmaceuticals, ATAI Life Sciences and others.
* Promising Treatment Resistant Hypertension Therapies such as CIN-107, Aprocitentan 12.5 mg, Patiromer, Spironolactone, Firibastat, LHW090, Darusentan and others.
Access DelveInsight's in-depth Treatment-Resistant Hypertension Pipeline Analysis for a closer look at promising breakthroughs @ Treatment-Resistant Hypertension Clinical Trials and Studies [https://www.delveinsight.com/sample-request/treatment-resistant-depression-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Treatment-Resistant Hypertension Emerging Drugs Profile
* Psilocybin: COMPASS Pathways
Psilocybin therapy is an approach being investigated for the treatment of mental health challenges. It combines the pharmacological effects of psilocybin, a psychoactive substance, with psychological support. Psilocybin is an active ingredient in some species of mushrooms, often referred to as 'magic mushrooms'. The company has developed a synthesised formulation of psilocybin, COMP 360, and is investigating the effectiveness of psilocybin therapy, initially in treatment-resistant depression.
* AXS-05: Axsome Therapeutics
AXS-05 is a novel, oral, investigational NMDA receptor antagonist with multimodal activity being developed for the treatment of central nervous system (CNS) conditions. AXS-05 consists of a proprietary formulation and dose of dextromethorphan (DM) and bupropion. The dextromethorphan component of AXS-05 is an antagonist of the NMDA receptor, an ionotropic glutamate receptor, and a sigma-1 receptor agonist. These actions modulate glutamatergic neurotransmission. The bupropion component of AXS-05 serves primarily to increase the bioavailability of dextromethorphan, and is a norepinephrine and dopamine reuptake inhibitor
The Treatment-Resistant Hypertension Pipeline report provides insights into
* The report provides detailed insights about companies that are developing therapies for the treatment of Treatment Resistant Hypertension with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Treatment Resistant Hypertension Treatment.
* Treatment Resistant Hypertension Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Treatment Resistant Hypertension Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Treatment Resistant Hypertension market.
Explore DelveInsight's expert-driven report today! @ [https://www.delveinsight.com/sample-request/treatment-resistant-depression-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Treatment-Resistant Hypertension Companies
Axsome Therapeutics, COMPASS Pathways, Merck Sharp & Dohme Corp., Navitor Pharmaceuticals, Inc., Taisho Pharmaceutical Co., Ltd., GH Research Limited, Novartis Pharmaceuticals, Reckitt Benckiser LLC, Relmada Therapeutics, Inc., SAGE Therapeutics, Navitor Pharmaceuticals, Sumitomo Dainippon Pharma, Alkermes, AbbVie, Janssen Pharmaceuticals, Celon Pharma, ACADIA Pharmaceuticals, Pherin Pharmaceuticals, ATAI Life Sciences and others.
Treatment-Resistant Hypertension Pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Oral
* Parenteral
* Intravenous
* Subcutaneous
* Topical.
* Molecule Type
Treatment-Resistant Hypertension Products have been categorized under various Molecule types such as
* Monoclonal Antibody
* Peptides
* Polymer
* Small molecule
* Gene therapy
* Product Type
Download DelveInsight's latest report to gain strategic insights into upcoming Therapies and key Developments @ [https://www.delveinsight.com/sample-request/treatment-resistant-depression-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Treatment-Resistant Hypertension Pipeline Report
* Coverage- Global
Treatment Resistant Hypertension Companies- Axsome Therapeutics, COMPASS Pathways, Merck Sharp & Dohme Corp., Navitor Pharmaceuticals, Inc., Taisho Pharmaceutical Co., Ltd., GH Research Limited, Novartis Pharmaceuticals, Reckitt Benckiser LLC, Relmada Therapeutics, Inc., SAGE Therapeutics, Navitor Pharmaceuticals, Sumitomo Dainippon Pharma, Alkermes, AbbVie, Janssen Pharmaceuticals, Celon Pharma, ACADIA Pharmaceuticals, Pherin Pharmaceuticals, ATAI Life Sciences and others.
* Treatment Resistant Hypertension Therapies- CIN-107, Aprocitentan 12.5 mg, Patiromer, Spironolactone, Firibastat, LHW090, Darusentan and others.
* Treatment Resistant Hypertension Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Treatment Resistant Hypertension Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Find out in DelveInsight's exclusive Treatment-Resistant Hypertension Pipeline Report-access it now! @ Treatment-Resistant Hypertension Emerging Drugs and Major Companies [https://www.delveinsight.com/sample-request/treatment-resistant-depression-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Treatment Resistant Depression: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Late Stage Products (Preregistration)
* AXS-05: Axsome Therapeutics
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* Psilocybin: COMPASS Pathways
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* SEP-378614: Sumitomo Dainippon Pharma
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Inactive Products
* Treatment Resistant Depression Key Companies
* Treatment Resistant Depression Key Products
* Treatment Resistant Depression- Unmet Needs
* Treatment Resistant Depression- Market Drivers and Barriers
* Treatment Resistant Depression- Future Perspectives and Conclusion
* Treatment Resistant Depression Analyst Views
* Treatment Resistant Depression Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=treatment-resistant-hypertension-clinical-trial-pipeline-expands-as-25-companies-driving-innovation-in-the-therapeutics-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/treatment-resistant-depression-pipeline-insight
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Treatment Resistant Hypertension Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight here
News-ID: 4374111 • Views: …
More Releases from ABNewswire
Unitee Distribution Redefines Online Home Goods Shopping with Customer-First App …
Unitee has emerged as a leading online retailer specializing in premium patio furniture, outdoor fire pits, and home goods for United States customers. The company distinguishes itself through exceptional customer service, fast and free shipping, hassle-free returns, and a commitment to donating a portion of profits to nonprofit organizations.
Unitee Distribution has established itself as a trusted destination for homeowners seeking to enhance their outdoor living spaces and interior environments with…
Galaxy Trend Unveils Creative Artistry and Premium Quality Products Through Glob …
Galaxy Trend, an innovative online retailer based in Victorville, California, has established itself as a premier destination for high-quality creative products featuring original artwork. The company has achieved significant expansion through global distribution networks and strategic partnerships, serving discerning customers who value both craftsmanship and artistic expression.
Galaxy Trend has emerged as a distinctive voice in the online retail landscape, carving out a unique position by prioritizing original artistic creation and…
Krew Supply Co Builds Competitive Clarity Across Industrial Tooling Markets with …
Krew Supply Co strengthened competitive positioning and procurement conversations across industrial tooling markets using Playwise HQ. By centralising competitor battlecards, objection handling, and field intelligence, the team improved consistency across product categories, responded faster in tenders, and built greater confidence in high-stakes B2B buying environments.
SYDNEY, Australia - 25 February, 2026 - Playwise HQ [https://playwisehq.com/], the AI-native competitive intelligence platform for B2B sales teams, today shared new customer results demonstrating how…
PITAKA Turns the Galaxy S26 Case Into a Programmable Control Hub With Aaron Butt …
Hong Kong, China - 25th Feb, 2026 - PITAKA [https://pitakagermany.com/] today introduces its Galaxy S26 case lineup featuring the Aaron Button, a built-in three-button shortcut system that transforms a traditional phone case into an intelligent hardware interface.
Image: https://www.abnewswire.com/upload/2026/02/c965846dc9c58a7700fa39917f7786c5.jpg
Designed for productivity and customization, Aaron Button allows users to assign programmable shortcuts to physical buttons integrated into the case. With a single press, users can launch apps, trigger smart home routines, activate…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
